Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Teamsters Union, et al v. Warner Chilcott Limited, et al
Case Number:
18-1065
Court:
Nature of Suit:
Companies
- Allergan PLC
- American Federation of State County & Municipal Employees
- Rochester Drug Cooperative Inc.
- United Food & Commercial Workers International Union
- Warner Chilcott Limited
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
-
January 24, 2019
No Redo On Asacol Class Decertification At 1st Circ.
The full First Circuit on Wednesday refused to reconsider a panel decision decertifying a class of buyers who allegedly overpaid for Allergan's ulcerative colitis drug Asacol, in what could be another blow against certification for proposed classes that may contain uninjured members.
-
November 21, 2018
Consumer Groups Push 1st Circ. To Redo Asacol Class Cert.
Law professors and two consumer interest groups urged the First Circuit on Tuesday to reconsider a decision last month decertifying a class of buyers who allegedly overpaid for the ulcerative colitis drug Asacol, arguing that class actions can't be disqualified just because some class members never suffered an injury.
-
October 16, 2018
1st Circ. Overturns Class Cert. In Allergan Price Fight
The First Circuit has overturned certification of a class of buyers who purportedly bought Allergan medicines at artificially high prices, saying the suit didn't offer a way to weed out large numbers of purchasers who never suffered any injury.
-
March 06, 2018
Legal Group Urges 1st Circ. To Flip Asacol Class Cert.
The Washington Legal Foundation on Monday backed Allergan PLC in a fight over class certification, telling the First Circuit that a Massachusetts federal judge shouldn't have certified a class of insurers who paid for an ulcerative colitis drug without parties tied to each state involved in the product-hopping suit.
-
February 26, 2018
Allergan Urges 1st Circ. To Reverse Asacol Class Cert.
Allergan PLC urged the First Circuit on Friday to reverse the certification of a class of buyers of an anti-inflammatory drug, accusing the putative class of "bootstrapping" claims from purchasers of the drug in just four states to bring claims under dozens of other states' antitrust laws.
-
January 25, 2018
Asacol Antitrust Trial Delayed To Let Allergan Appeal Class
The First Circuit on Thursday granted an indefinite delay of an antitrust trial slated to start next week, allowing Allergan PLC to appeal the certification of a class of unions and grocers who claim the company and a subsidiary manipulated the market with a monopolistic hard switch of available anti-inflammatory drugs.